Income Statement
MIRUM PHARMACEUTICALS, INC.
MIRM
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Revenue
|
521.31 | 336.89 | 186.37 | 77.06 | 19.14 | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - |
|
Gross Profit
|
521.31 | 336.89 | 186.37 | 77.06 | 19.14 | - | - |
|
Operating Expenses
|
543.45 | 424.49 | 295.53 | 208.28 | 192.55 | 104.30 | 54.74 |
|
Research & Development
|
186.18 | 140.63 | 102.61 | 106.84 | 131.43 | 81.61 | 42.99 |
|
Selling, General & Administrative
|
257.03 | 202.22 | 145.88 | 89.07 | 59.22 | 22.69 | 11.75 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - |
|
Operating Income
|
-22.14 | -87.61 | -109.15 | -131.22 | -173.41 | -104.30 | -54.74 |
|
Non-Operating Income
|
-0.71 | -0.69 | 53.27 | 10.85 | -89.46 | -1.03 | -2.21 |
|
Interest Income
|
12.73 | 13.79 | 13.74 | 3.86 | 0.37 | 1.56 | 2.23 |
|
Interest Expense
|
14.39 | 14.31 | 10.05 | 16.00 | 17.60 | 0.30 | - |
|
Other Non-Op Income / Expense
|
2.37 | 1.21 | -2.82 | 0.37 | -0.58 | -0.19 | -0.02 |
|
Income Before Tax
|
-21.43 | -86.91 | -162.42 | -142.07 | -83.95 | -103.26 | -52.53 |
|
Income Tax Expense
|
1.94 | 1.03 | 0.99 | -6.41 | 0.04 | 0.01 | 0.02 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - |
|
Net Income
|
-23.36 | -87.94 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - |
|
EBITDA
|
2.11 | -63.98 | -98.33 | -127.98 | -172.82 | -103.99 | -54.60 |
|
Earnings Per Share (Basic)
|
-0.47 | -1.85 | -4.00 | -4.01 | - | - | - |
|
Diluted EPS
|
-0.47 | -1.85 | -4.00 | -4.02 | - | - | - |
|
Weighted Average Shares
|
50.20 | 47.52 | 40.89 | 33.84 | - | - | - |
|
Diluted Weighted Avg Shares
|
50.20 | 47.52 | 40.89 | 33.98 | - | - | - |
|
Comprehensive Income
|
-22.64 | -89.96 | -161.55 | -135.85 | -84.11 | -103.32 | -52.42 |